Recent Finacing
Recent Raise
Serina Therapeutics develops polyoxazoline (POZ) polymer-drug conjugates that modify pharmacokinetics to prolong activity and enable receptor-targeted delivery for oncology and other therapeutic applications.
Focus Areas
Total Raised
Funding round